from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2123/PPE37

LFCtreatmentdescriptionclass of inhibitor

-0.225

Amikacinug/mL Amikacintranslation

-0.077

Cap5-10ug/mL Capreomycintranslation

-0.304

Rox10-50 ug/mL Roxithromycintranslation

-0.289

SM2-5 ug/mL Streptomycintranslation

-0.346

Tet5-10 ug/mL Tetracyclinetranslation

-0.646

Rif0.2-5ug/mL Rifampicintranscription

-0.284

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.388

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.613

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.367

CPZ10-50 ug/mL Chlorpromazinerespiration

3.384

Clofazimine10-13 ug/mL Clofaziminerespiration

0.263

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.655

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.229

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.459

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.218

Econazole10-24 ug/mL Econazole (azole drug)respiration

2.089

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.561

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.956

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.734

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.792

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.755

Nigericin50 uM Nigericinrespiration

-0.328

TRC10-150 ug/mL Triclosanrespiration

-0.172

TRZ10-25 ug/mL Thioridazinerespiration

2.245

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.628

menadione6-10 ug/mL Menadionerespiration

1.997

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

1.078

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

1.715

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.645

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.559

NRP_1Non-replicating persistence stage 1dosRassociated

-0.243

Amp0.2mg/mL AmpicillincellWall

-0.574

Cephalexin20-100 ug/mL CephalexincellWall

0.219

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.102

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.193

EMB10-20 ug/mL EthambutolcellWall

-0.288

Eta12-40 ug/mL EthionamidecellWall

-0.466

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.358

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.764

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.605

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.258

BZA0.12 mg/mL BenzamidearomaticAmides

-0.241

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.060

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.131

H2O24 mM hydrogen peroxideDNAdamaging

-0.438

Levo10 ug/mL LevofloxacinDNAdamaging

-0.368

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.322

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.396

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.466

UVUV-irradiationDNAdamaging

0.203

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.412

Antimycin12.5-50 ug/mL Antimycin A?

-0.782

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.794

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.082

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.388

PA8240.2-2 ug/mL PA-824?

-0.768

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.040

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.887

Verapamil50 uM Verapamil?

-0.840

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.230

methoxatin10-20 ug/mL Methoxatin?